T1	Participants 22 51	children with acute leukemia.
T2	Participants 87 238	One hundred four children with advanced leukemia in relapse (74 with acute lymphocytic leukemia [ALL] and 30 with acute nonlymphocytic leukemia [ANLL])
T3	Participants 396 413	Children with ALL
T4	Participants 506 537	29 evaluable patients with ANLL
T5	Participants 798 838	17 children with ALL and in 7 with ANLL.
T6	Participants 839 886	Fatal cardiac toxicity occurred in one patient.
T7	Participants 1551 1588	heavily pretreated patient population
